Russia Sees 7% Growth in Pediatric High-Tech Medical Care Over Five Years
29 August 2024
Russian Health Minister Mikhail Murashko announced a 7% increase in specialized and high-tech medical care for children in Russia over the past five years. This growth is largely due to the introduction of advanced medical technologies, especially in pediatric trauma and orthopedics. Since 2018, over 40 major medical facilities have been built, with additional projects slated for completion by 2025.
Russia’s Leading Radiology Center Receives Certification for In-House Drug Production
29 August 2024
The National Medical Research Radiological Center of the Ministry of Health of the Russian Federation has become the first in the country to receive certification for in-house pharmaceutical production. This milestone allows the center to manufacture drugs tailored specifically for their patients’ needs.
28 August 2024
A survey of more than 800 biopharma executives shows that sustainability has become an increasingly important priority but that companies are struggling to achieve it and as a result are putting their business at risk.
Innovative mass spec method may improve oligonucleotide therapeutic analysis
28 August 2024
The nonIP-RP-LC-MS method provides an “easy, reliable, and cost-effective” approach for bioanalysing oligonucleotide therapies.
Chinese Authority Approves Severe Eosinophilic Asthma Maintenance Treatment for Ages 12 and Up
27 August 2024
Fasenra, which has been approved since 2019 in the United States in a pre-filled, single-use auto-injector form that can be administered either in a doctor’s office or at home, is now approved in China for age 12 and up.
Semi-automatic method could provide “superior” bacterial characterisation analysis
27 August 2024
The analysis technique offers “significant” advantages over traditional colony forming unit (CFU) counts, according to the paper.
Alzheimer’s drug milestone “bittersweet” for certain patients
26 August 2024
The first new dementia medicine to be licensed in over two decades shows for first time, that the course of Alzheimer disease can be modified and slow cognitive decline.
Russia to Send Monkeypox Diagnostic Tests to African Countries
26 August 2024
The Federal Service for the Oversight of Consumer Protection and Welfare (Rospotrebnadzor) has announced the delivery of monkeypox diagnostic tests to African countries. According to the agency’s report, Congo has expressed a keen interest in obtaining Russian tests and enhancing collaboration regarding epidemic response. In response to this initiative, Rospotrebnadzor will provide Russian diagnostic drugs to other African countries.
Health Ministry included 4 new drugs in the lists of vital and essential drugs
23 August 2024
The Health Ministry’s Commission for the Formation of Lists of Vital and Essential Drugs and High-Care Drugs reviewed nine drugs proposed for inclusion in the Vital and Essential Drugs List.
Russian authorities approved AI assistant to detect tumors during colonoscopy
23 August 2024
Federal Service for Surveillance in Healthcare (Roszdravnadzor) has issued a registration certificate for a medical device featuring artificial intelligence, which has been developed by the Ryzhikh National Medical Research Center of Proctology, in collaboration with Alnisoft and the Ministry of Health of the Russian Federation.
October 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
DSM Group predicts the Russian pharmaceutical market will grow by 10% annually
18 October 2024
An extra 6.1 billion rubles will be allocated for drug provision in 2025
18 October 2024
Pharmasyntez to build heparin production plant in Tatarstan
17 October 2024
17 October 2024